TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.520
+0.040 (2.70%)
At close: May 13, 2025, 4:00 PM
1.539
+0.019 (1.26%)
Pre-market: May 14, 2025, 8:48 AM EDT
TherapeuticsMD Market Cap
TherapeuticsMD has a market cap or net worth of $17.59 million as of May 14, 2025. Its market cap has decreased by -10.70% in one year.
Market Cap
17.59M
Enterprise Value
19.71M
1-Year Change
-10.70%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since March 27, 2012, TherapeuticsMD's market cap has decreased from $210.70M to $17.59M, a decrease of -91.65%. That is a compound annual growth rate of -17.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 17.60M | 77.78% |
| Dec 31, 2024 | 9.90M | -58.40% |
| Dec 29, 2023 | 23.80M | -55.01% |
| Dec 30, 2022 | 52.90M | -64.99% |
| Dec 31, 2021 | 151.10M | -54.23% |
| Dec 31, 2020 | 330.10M | -49.70% |
| Dec 31, 2019 | 656.20M | -27.60% |
| Dec 31, 2018 | 906.30M | -30.67% |
| Dec 29, 2017 | 1.31B | 15.24% |
| Dec 30, 2016 | 1.13B | -38.50% |
| Dec 31, 2015 | 1.84B | 165.63% |
| Dec 31, 2014 | 694.30M | -8.08% |
| Dec 31, 2013 | 755.30M | 144.20% |
| Dec 31, 2012 | 309.30M | 46.80% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |